title: Use of a phosphorus-enriched hemodialysate to prevent hypophosphatemia in a patient with renal failure-related pericarditis.
abstract: We describe a patient who suffered from renal failure-associated pericarditis and underwent daily 3.5-hour hemodialysis treatments for 17 days. The initially elevated serum phosphorus level gradually fell to below normal on days 11 and 12 as a result of the intensive dialytic therapy. Phosphorus was added to the "base concentrate" of a dual-concentrate, bicarbonate-based dialysate delivery system on days 13 to 17. Because of this phosphorus-enrichment, we were able to maintain the patient's serum phosphorus levels within normal limits in spite of continued daily dialysis treatments.
authors.affiliation: Department of Medicine, Veterans Affairs Hospital, Hines, Illinois 60141, USA.
authors.forename: C
authors.initials: C
authors.lastname: Emelife-Obi
authors.forename: M T
authors.initials: MT
authors.lastname: Chow
authors.forename: H
authors.initials: H
authors.lastname: Qamar-Rohail
authors.forename: D J
authors.initials: DJ
authors.lastname: Leehey
authors.forename: V C
authors.initials: VC
authors.lastname: Gandhi
authors.forename: T S
authors.initials: TS
authors.lastname: Ing
mesh_terms: D015312:Hemodialysis Solutions / Q000737:chemistry*; D006801:Humans; D017674:Hypophosphatemia / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008875:Middle Aged; D010493:Pericarditis / Q000209:etiology*; D010758:Phosphorus / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D006435:Renal Dialysis
chemical_list: D015312:Hemodialysis Solutions; D010758:Phosphorus